Article Details

A Phase II Study of Cemiplimab Immunotherapy Alone and with RP1 in People with Cutaneous ...

Retrieved on: 2021-06-22 22:52:30

Tags for this article:

Click the tags to see associated articles and topics

A Phase II Study of Cemiplimab Immunotherapy Alone and with RP1 in People with Cutaneous .... View article details on hiswai:

Excerpt

RP1 causes the herpes simplex virus to spread from tumor cell to tumor cell and turn on the immune system to attack cancer cells. It is given as an ...

Article found on: www.mskcc.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up